Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mixed-beam approach for high-risk prostate cancer: Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300).
Gugliandolo SG, Marvaso G, Comi S, Pepa M, Romanò C, Zerini D, Augugliaro M, Russo S, Vischioni B, Valvo F, Giandini T, Avuzzi B, Valdagni R, Ciardo D, De Cobelli O, Jereczek-Fossa BA, Cattani F, Orecchia R. Gugliandolo SG, et al. Among authors: avuzzi b. Phys Med. 2020 Aug;76:327-336. doi: 10.1016/j.ejmp.2020.07.012. Epub 2020 Aug 2. Phys Med. 2020. PMID: 32750548
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
Bampo C, Alessi A, Fantini S, Bertarelli G, de Braud F, Bombardieri E, Valvo F, Crippa F, Di Bartolomeo M, Mariani L, Milione M, Biondani P, Avuzzi B, Chiruzzi C, Pietrantonio F. Bampo C, et al. Among authors: avuzzi b. Oncology. 2013;84(4):191-9. doi: 10.1159/000345601. Epub 2013 Jan 15. Oncology. 2013. PMID: 23328390 Clinical Trial.
Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer.
Carillo V, Cozzarini C, Rancati T, Avuzzi B, Botti A, Borca VC, Cattari G, Civardi F, Esposti CD, Franco P, Girelli G, Maggio A, Muraglia A, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Zeverino M, Valdagni R, Fiorino C. Carillo V, et al. Among authors: avuzzi b. Radiother Oncol. 2014 Apr;111(1):100-5. doi: 10.1016/j.radonc.2014.02.006. Epub 2014 Mar 13. Radiother Oncol. 2014. PMID: 24631144
Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Results of a cohort study.
Cozzarini C, Rancati T, Carillo V, Civardi F, Garibaldi E, Franco P, Avuzzi B, Esposti CD, Girelli G, Iotti C, Palorini F, Vavassori V, Valdagni R, Fiorino C. Cozzarini C, et al. Among authors: avuzzi b. Radiother Oncol. 2015 Aug;116(2):185-91. doi: 10.1016/j.radonc.2015.07.048. Epub 2015 Aug 11. Radiother Oncol. 2015. PMID: 26276529 Clinical Trial.
Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy.
Palorini F, Rancati T, Cozzarini C, Improta I, Carillo V, Avuzzi B, Casanova Borca V, Botti A, Degli Esposti C, Franco P, Garibaldi E, Girelli G, Iotti C, Maggio A, Palombarini M, Pierelli A, Pignoli E, Vavassori V, Valdagni R, Fiorino C. Palorini F, et al. Among authors: avuzzi b. Radiother Oncol. 2016 Jan;118(1):92-8. doi: 10.1016/j.radonc.2015.11.036. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777123 Clinical Trial.
"What if…": decisional regret in patients who discontinued active surveillance.
Repetto C, Rancati T, Magnani T, Alvisi MF, Avuzzi B, Badenchini F, Marenghi C, Stagni S, Maffezzini M, Villa S, Villa S, Salvioni R, Valdagni R, Bellardita L. Repetto C, et al. Among authors: avuzzi b. Tumori. 2016 Dec 1;102(6):562-568. doi: 10.5301/tj.5000564. Epub 2016 Sep 22. Tumori. 2016. PMID: 27716881
56 results